This site is intended for UK healthcare professionals only and contains promotional information.UK Flag Please visit the MHRA Yellowcard site to report an Adverse Event.

Anti-infective webinars

Click the product names to view Prescribing Information for TENKASI®(oritavancin), QUOFENIX®(delafloxacin) and VABOREM®(meropenem/vaborbactam)

<h3>Perspectives on the clinical use of antibiotics for difficult to treat pathogens in patients with cystic fibrosis</h3>

Perspectives on the clinical use of antibiotics for difficult to treat pathogens in patients with cystic fibrosis

Presented by: Professor John E Moore, CF Consultant Microbiologist Northern Ireland Regional Adult Cystic Fibrosis Centre, Belfast City Hospital.
Content Summary: 1. Understand the microbiology in treating complicated chest infections in CF patients.
2. Update on treatment options for MDR gram-negatives in respiratory.

Prescribing Information can be found below and at top of page.

18th October 2022 (webinar sponsored by Menarini)
<h3>The role of an AMS pharmacist in the management of Gram negative infections</h3>

The role of an AMS pharmacist in the management of Gram negative infections

Presented by: Frances Garraghan, Antimicrobial Stewardship Pharmacist, Manchester University NHS Foundation Trust.
Content Summary: 1. Patient centred antimicrobial stewardship.
2.Co-ordinating multi-disciplinary decisions and monitoring patient outcomes.

Prescribing Information can be found below and at top of page.

12th October 2022, BSAC Gram-Negative Conference

<h3>Unexpected outcomes? Two case studies of difficult-to-treat gram-negative infections</h3>

Unexpected outcomes? Two case studies of difficult-to-treat gram-negative infections

Presented by: Dr Kavita Sethi, Consultant Microbiologist and lead clinician at Leeds Teaching Hospital NHS Trust and Honorary Clinical Lecturer at the University of Leeds.
Professor Ignacio Martin-Loechesis, Consultant in Intensive Care Medicine at St James’s Hospital and Professor at Trinity College, Dublin, Ireland.
Content summary: Presentations on two clinical case studies from the UK and Ireland in the use of VABOREM®(meropenem/vaborbactam).

Prescribing Information can be found below and at top of page.

22nd September 2022, FIS conference
<h3>Positioning quinolones to support infection management in Scotland</h3>

Positioning quinolones to support infection management in Scotland

Presented by: Professor John E Moore, CF Consultant Microbiologist, Northern Ireland Regional Adult Cystic Fibrosis Centre, Belfast City Hospital.
Dr John Cunniffe, Consultant Microbiologist, Countess of Chester NHS Foundation Trust, Cheshire.

Content Summary: 1. In July 2022 SMC published their assessment on QUOFENIX (delafloxacin) for treatment of ABSSSI (for full guidance click here delafloxacin (Quofenix) (scottishmedicines.org.uk).
2. The potential role of a quinolone in assisting early discharge with patients with complex SSTI.

Prescribing Information can be found below and at top of page.

8th September 2022 (webinar sponsored by Menarini)

*LAGs - Long-acting lipoglycopeptides


Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to A. Menarini Farmaceutica Internazionale SRL. Phone 0800 085 8678 or email: [email protected]


These medicinal products are subject to additional monitoring

PP-AI-UK-0415 August 2024

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store.

Adverse events should also be reported to A. Menarini Farmaceutica Internazionale SRL.

Phone 0800 085 8678